New guide shows how to reduce chemotherapy risk

The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.

Daridorexant is approved to treat insomnia in adults who have difficulty with sleep onset or maintenance.

A perspective on the CMS Innovation Center roundtable on health equity.

Clinicians are seeking ways to reduce opioid exposure in a variety of settings. Could the use of acetaminophen before opioid use reduce opioid treatment duration in the inpatient setting?

The FDA approved efgartigimod, which is being sold under the brand name Vyvgart and could foment price competition with Soliris (eculizumab) and other treatments usually reserved for severe or refractory cases.

Let’s raise a glass to all the pharmacy owners who are improving patient health outcomes by providing innovative services.